Drug Intelligence & Clinical Pharmacy Template
Write in a clean editor, then format for Drug Intelligence & Clinical Pharmacy in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Drug Intelligence & Clinical Pharmacy format
Drug Intelligence & Clinical Pharmacy is a peer-reviewed journal published by SAGE, covering Pharmaceutical Practices and Patient Outcomes, Pharmaceutical studies and practices, Pharmacy and Medical Practices.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Drug Intelligence & Clinical Pharmacy, 12(3), pp. 45–58.
Formats any DOI in Drug Intelligence & Clinical Pharmacy style. No sign-up. |
| Publishes research in | Pharmaceutical Practices and Patient Outcomes Pharmaceutical studies and practices Pharmacy and Medical Practices Antibiotics Pharmacokinetics and Efficacy Human auditory perception and evaluation |
| ISSN | 0012-6578 |
| h-index | 52 |
| i10-index | 651 |
| Total citations | 21,696 |
| Top institutions publishing here | University of Illinois Chicago |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Drug Intelligence & Clinical Pharmacy per year
Citation impact of Drug Intelligence & Clinical Pharmacy by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Drug Intelligence & Clinical Pharmacy
A brief review of pK a values and their uses in pharmacy practice is presented. Tables of pK a values for 400 medicinal compounds, of pH values of 18 body fluid sites, and of electron-inducing chemical substituents are provided. Adequate literature sources are included to permit further reference to the more detailed aspects of conditions…
Temazepam is a benzodiazepine derivative indicated for the treatment of insomnia. Pharmacokinetic studies of the hard capsule formulation indicate that the mean time to peak is 2.99 hours and the mean elimination half-life is 14.7 hours. Sleep laboratory studies have demonstrated improvements in all sleep parameters except sleep onset latency. Clinically, patients report improvements in…
Use of recommended IV aminophylline dosage regimens in 48 older, acutely ill, hospitalized patients with chronic obstructive pulmonary disease (COPD) resulted in excessive plasma theophylline concentrations in 29 percent of these patients. A mean dose of 0.89 mg/kg/hr produced a plasma concentration which ranged from 7 to 52 mcg/ml with a mean of 21.9 mcg/ml.…